Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastoma Multiforme, Adult”

515 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 515 results

Testing effectiveness (Phase 2)Study completedNCT02364206
What this trial is testing

Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
Adult Glioblastoma
Centre Jean Perrin 18
Not applicableLooking for participantsNCT05954858
What this trial is testing

Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma

Who this might be right for
Glioma, MalignantGlioblastomaGlioblastoma Multiforme+4 more
Northwell Health 32
Testing effectiveness (Phase 2)Looking for participantsNCT05765812
What this trial is testing

Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeAstrocytoma, Grade III
Debiopharm International SA 116
Testing effectiveness (Phase 2)Study completedNCT00619112
What this trial is testing

Temozolomide in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Recurrent Central Nervous System Neoplasm
University of California, San Francisco 60
Testing effectiveness (Phase 2)UnknownNCT00492687
What this trial is testing

Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
San Diego Pacific Oncology & Hematology Associates 80
Testing effectiveness (Phase 2)Study completedNCT00006358
What this trial is testing

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44
Not applicableStudy completedNCT00897663
What this trial is testing

Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 56
Early research (Phase 1)UnknownNCT00083096
What this trial is testing

Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 30
Testing effectiveness (Phase 2)Study completedNCT01310868
What this trial is testing

Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma

Who this might be right for
Glioblastoma
University College, London 59
Early research (Phase 1)Study completedNCT00002824
What this trial is testing

Gene Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Study completedNCT00014170
What this trial is testing

Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 92
Testing effectiveness (Phase 2)Study completedNCT01331291
What this trial is testing

Bosutinib in Adult Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Massachusetts General Hospital 36
Not applicableLooking for participantsNCT06954636
What this trial is testing

Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study

Who this might be right for
Glioblastoma Multiforme, AdultGlioblastoma or GliosarcomaGlioblastoma, Adult
Sied Kebir 128
Early research (Phase 1)Study completedNCT00784914
What this trial is testing

A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
City of Hope Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT00902577
What this trial is testing

MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 50
Early research (Phase 1)Looking for participantsNCT05557292
What this trial is testing

RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma

Who this might be right for
GlioblastomaRecurrent Glioblastoma
Nicholas Butowski 48
Testing effectiveness (Phase 2)Study completedNCT00022256
What this trial is testing

Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00014677
What this trial is testing

NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Neurocrine Biosciences
Early research (Phase 1)Ended earlyNCT00671801
What this trial is testing

Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I

Who this might be right for
Malignant Gliomas
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)UnknownNCT00275067
What this trial is testing

Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University 50
Load More Results